EGenesis is a Biotech company based in Cambridge. It has raised $481M in total funding. Latest round: Series D.
EGenesis is a Biotech company based in Cambridge. EGenesis has raised $481M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series D announced in September 2024. The round record for EGenesis runs through 2024; nothing later has been disclosed. Investors on record include Lux Capital, ARCH Ventures, Khosla Ventures, Farallon Capital Management, Alta Partners, Fresenius Medical Care Ventures and 6 others. 12 distinct backers are named across the disclosed rounds.
We update the EGenesis record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Cambridge and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026